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Introduction
   It is well established that different forms of stress, such as psychological and physical stress, produce a
pronounced antinociception in experimental animals (Lewis et al. 1980; Panocka et aL 1986; Kitchen and Pinker
1990; Marek et aL 1991; Kamei et aL 1992, 1994). Such stress-induced antinociception is mediated by complex
endogenous antinociceptive systems, which involve both opioid and non-opioid mechanisms (Lewis et aL 1980;
Panocka et al. 1986; Marek et aL 1991). We previously demonstrated that the antinociception induced by
physical stress, such as forced swimming, is greater in diabetic mice than in non-diabetic mice (Kamei et al.
1992, 1994). However, the effect of diabetes on psychological stress-induced antinociception is not yet clear.
Many studies have suggested that diabetes or hyperglycemia affects the sensitivity of laboratory animals to
various pharmacological agents (Marshall et al. 1976; Simon and Dewey 1981; MacKenzie and Trulson 1989).
Recently, it has been reported that the anxiolytic effect of diazepam is less marked in diabetic rats than in
non-diabetic rats (Ramanathan et al. 1998). Furthermore, we recently reported that the diazepam-induced loss
of the righting reflex in diabetic mice was less than that in non-diabetic mice (Ohsawa and Kamei 1999). Based
on these results, it is also possible that benzodiazepine receptor function may be altered in diabetic mice. Thus,
it is possible that altered benzodiazepine receptor function in diabetic mice may affect their sensitivity to
stress. The aim of the present study was to investigate the effect of diabetes on socio-psychological
stress-induced antinociception in mice, and the possible role of benzodiazepine receptor function in this
socio-psychological stress-induced antinociception.
Induction of diabetes
   Male ICR mice (Tokyo Animal Laboratory Inc. Tokyo, Japan), weighing about 20 g at the beginning of the
experiments, were used. They had free access to food and water in an animal room that was maintained at 24
Å} 10C with a 12-hr light-dark cycle. Animals were rendered diabetic by an injection of streptozotocin (200 mg/
kg, i.v.) prepared in O.1 N citrate buffer at pH 4.5. Age-matched control mice were injected with vehicle alone.
The experiments were conducted 2 weeks after injection of vehicle or streptozotocin. Mice with serum glucose
levels above 400 mg/dL were considered diabetic.
Exposure to socio-psychological stress
   Mice were exposed to psychological stress in the compartment of a communication box. Parallel electrodes,
3mm in diameter, located every 10mm, were set on the floor of the compartment (10Å~10cm). Mice were
isolated in each compartment during the stress session. Each compartment was separated by transparent
plastic walls. Experimental mice were isolated in each compartment as the "responder" during the stress
session. The electrodes for "responder" mice were covered by plastic panels to shield electricity. The same
series of electrical stimulations was given to sex- and age-matched "sender" mice, which were located in the
adjacent compartment, so that they could communicate with "responder" mice. The electric current was
automatically regulated at O.25 mA by a shock generator (NS-SGOI, Neuroscience, Inc. Tokyo, Japan). Ten-
second stimulations were given repeatedly every 30 s (shock amplitude, O.25 mA; voltage, 150 V/cm). The
shock duration was 5-15 min depending on the experiment. Applied voltage was automatically regulated at
approximately 150 V/cm to maintain a fixed shock amplitude of O.25 mA, which was the minimum amplitude
that the shock generator could produce. In a preliminary study, no animal was injured or died of this electrical
stimulation. "Responder" mice received only psychological stimuli.
Assay of antinociception
   The antinociceptive response was evaluated by the tail-flick test, using radiant heat as a stimulus, which
was performed before stress (pre-stress latency) and O, 30 and 60 min after stress. The intensity of the thermal
stimulus was adjusted so that the animal flicked its tail in 2-3 s. A cut-off latency of 10 s was used to prevent
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injury to the tail. Animals which did not respond within 10s were removed and assigned a score of 10s.
Percent antinociception was calculated for each animal as % antinociception=100Å~(post drug latency-pre
drug latency)/(10-pre drug latency).
               Effect of diabetes on socio-psychological stress-induced antinociception
   As shown in Fig. 1, exposure to socio-psychological stress for 5, 10 and 15min produced duration-
dependent antinociception, as evidenced by a marked increase in the latency in the tail-flick test, in diabetic
mice. However, in non-diabetic mice, no appreciable antinociception was found even in the case of socio-
psychological stress for 15 min. This effect reached its peak immediately after exposure to socio-psychological
stress, and then decreased. Thus, a time interval of immediately after exposure to 15 min after initiating stress
was chosen for experiments designed to quantify the effects of benzodiazepine receptor ligands on socio-
psychological stress-induced antinociception.
Effect of benzodiazepine receptor agonist and antagonist on socio-psychological
             stress-induced antinociception in diabetic mice
Intraperitoneal injection of diazepam, at doses of O.1 and O.3 mg, dose-dependently antagonized SOCIO-
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Time course of socio-psychological stress-induced antinociception in non-diabetic (open symbol)
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stress-induced antinociception. The antino-
ciceptive effect was determined immedia-
telyafter exposure to stress for 15min.
Flumazenil (O.1, O.3 and lmg/kg) were
injected i.v. 5min before the exposure to
stress. Each column represents the mean with
S. E. (n= 10). *PÅqO.05 vs. respective vehicle-
treated group.
-
2-
Proc. Hoshi Univ, No. 42, 2000
1oo
= 80
.9
-tL,
8 6o
' 6g
' E 4o
• c
etse 2o
                             o
                                Vehiclel 2 Vehiclel 2
                                      B-CCM B-CCM
                                    (mg/kg, i.v.) (mg/kg, i.v.)
Figure 4 Effects of methyl B-carboline-3-carboxylate (B-CCM) on socio-psychological stress-induced antinociception.
        The antinociceptive effect was determined immediately after exposure to stress for 15 min. Diazepam (O.1
        and O.3 mg/kg) were injected i.v. 5 min before the exposure to stress. Each colurnn represents the mean
        with S.E. (n= 10). *PÅqO.05 vs. respective vehicle-treated group.
psychological stress-induced antinociception (Fig. 2). Diazepam (O.3mg) reduced the socio-psychological
stress-induced antinociception in diabetic mice to the level observed in non-diabetic mice. Furthermore, i.v.
treatment with flumazenil (O.1, O.3 and 1 mg/kg), a benzodiazepine receptor antagonist, also dose-dependently
and significantly reduced socio-psychological stress-induced antinociception in diabetic mice (Fig. 3). However,
flumazenil (1 mg/kg, i.v.) had no significant effect on socio-psychological stress-induced antinociception in
non-diabetic mice. On the other hand, i.v. pretreatment with a benzodiazepine receptor inverse agonist, B-CCM,
at doses of 1 and 2 mg/kg, significantly and dose-dependently enhanced socio-psychological stress-induced
antinociception in non-diabetic mice (Fig. 4). However, socio-psychological stress-induced antinociception in
non-diabetic mice was not affected by i.v. treatment with B-CCM.
Discussion and conclusion
   Our results demonstrated that socio-psychological stress produced marked antinociception in diabetic
mice, but not in non-diabetic mice. Furthermore, the potency of this antinociceptive effect increased in
proportion to the duration of exposure to stress. This antinociception in diabetic mice was significantly
reduced by treatment with diazepam. These results indicate that socio-psychological stress-induced anti-
nociception in diabetic mice is a result of the stress response. Recently, we reported that the duration of the
diazepam-induced loss of the righting reflex was shorter in diabetic mice than in non-diabetic mice (Ohsawa
and Kamei 1999). Furthermore, the seizure threshold of a benzodiazepine receptor inverse agonist, B-CCM, was
markedly increased in diabetic mice compared to that in non-diabetic mice (Ohsawa and Kamei 1999). It has
been reported that the anxiolytic effect of diazepam is less marked in diabetic rats than in non-diabetic rats
(Ramanathan et al. 1998). On the other hand, Ramanatha et aL (1998) reported that hyperglycemic rats
exhibited augmented anxiety in open-field exploratory behavior, elevated plus maze and elevated zero maze
behavior, and social interaction tests. The above characteristics indicate that dysfunction of benzodiazepine
receptors exists in diabetic mice. Stress-induced changes in GABA or benzodiazepine recognition sites, as well
as changes in the effector component of the receptor, have been well demonstrated. Indeed, stressful stimulus
causes a sudden decrease in GABA receptor binding in rat brain (Biggio et al. 1981); this effect is mimicked by
anxiogenic B-carbolines and reversed by diazepam (Biggio et al. 1984). Furthermore, forced swimming stress
induces a rapid fall in the density of GABAA/benzodiazepine receptor in the brain (Medina et aL 1983). Thus,
it is possible that the enhancernent of socio-psychological stress-induced antinociception in diabetic mice may
be due to the dysfunction of GABAA/benzodiazepine receptors. In the present study, we also observed that
treatment with flumazenil, a benzodiazepine receptor antagonist, significantly antagonized the socio-
psychological stress-induced antinociception in diabetic mice. On the other hand, B-CCM, a benzodiazepine
receptor inverse agonist, significantly and dose-dependently enhanced the socio-psychological stress-induced
antinociception in non-diabetic, but not in diabetic mice. These results suggest that some endogenous
substance(s) that act(s) as an inverse benzodiazepine receptor agonist may also be involved in the enhancement
of socio-psychological stress-induced antinociception in diabetic mice. A polypeptide with high athnity for
benzodiazepine receptors was originally isolated from brain tissue of rodents and humans, and called diazepam
binding inhibitor (Guidotti et al. 1983). Diazepam binding inhibitor has been reported to exert benzodiazepine
receptor inverse agonist activity, since it elicits a proconflict response in behavioral paradigms when injected
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i.c.v. in the rat (Guidotti et al. 1983). Furthermore, elevated levels of a diazepam binding inhibitor-like
immunoreactive compound have been reported in patients diagnosed with depression with concomitant
anxiety (Barbaccia et al. 1986). Diazepam binding inhibitor has been previously shown to inhibit glucose-
stimulated insulin release from pancreatic isletB cells (Chen et al. 1988; Borboni et al. 1991). Suk et al. (1999)
demonstrated that cDNA related to diazepam binding inhibitor was expressed in most tissues including liver,
lung, tonsil and thymus, in addition to pancreatic islet and sera in diabetic patients. Based on these results, it
is tempting to speculate that the diazepam binding inhibitor level is capable of increasing rapidly in the
diabetic condition. Thus, it is possible that the increase in diazepam binding inhibitor release rnay be due, at
least in part, to the enhancement of socio-psychological stress-induced antinociception in diabetic mice.
However, further studies are needed to address this problem.
   In conclusion, socio-psychological stress produced marked antinociception in diabetic mice. The enhance-
ment of the socio-psychological stress-induced antinociception in diabetic mice may be due to an increase in an
endogenous negative allosteric modulator of benzodiazepine receptors, such as diazepam binding inhibitor or
B-carbolines, and/or dysfunction of central GABAA/benzodiazepine receptors.
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